• The Pediatric Research Equity Act of 2003 (S 650) would require drug companies that seek FDA approval for a new indication, dosage, dosing regimen, or active drug ingredient to conduct trials with children unless the FDA grants the company a waiver. About 75 percent of medications prescribed for children are tested only in adults before being granted FDA approval. The Senate Health, Education, Labor, and Pensions Committee approved the bill last month with an expiration date of 2007. The bill was introduced by Sens. Mike DeWine (R-Ohio), Judd Gregg (R-N.H.), Christopher Dodd (D-Conn.), and Hillary Rodham Clinton (D-N.Y.).